ArticleThe Pan African medical journal2025
Updates on the polio surveillance action plan's key performance indicators: East and Southern African countries (January 2022 to December 2023).
Article in The Pan African medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Polio transition in the African Region: progress, challenges and prospects for health systems integration.BMC infectious diseases · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The Global Polio Eradication Initiative (GPEI) partners are closely monitoring the progress of the implementation of key strategic activities of the polio eradication strategy for the years 2022-2026. This is being done using the Global Polio Surveillance Action Plan 2022-2024, which includes a set of indicators to track progress. All countries in the ESA sub-region have been informed about these key performance indicators, and the World Health Organization (WHO) is keeping a weekly eye on their implementation. We conducted a descriptive secondary analysis of field Acute Flaccid Paralysis (AFP) surveillance data compiled from 19 countries of East and Southern Africa for the period of January 2022 to December 2023. During the period, Seychelles did not report any AFP case, and therefore the country is excluded from the final analysis. A total of 18,078 AFP cases were detected, reported, and verified from nineteen countries in ESA and we found 8,049 females (44.5%) and 10,029 males (55.5%). This shows a male child was more likely to get AFP compared to a female child (11% difference, p < 0.0001). We noticed a significant increase in prompt AFP cases detection of 4% and an increased number of cases investigated within 11 days from the date of onset of paralysis from 7,790 (89%) in 2022 to 8,246 (91%) in 2023 (2% change, p < 0.0001). The two AFP surveillance quality indicators in the study period rose from 4.4 in 2022 to 4.7 in 2023 (0.3 increase, p < 0.0001). Of the 8,964 AFP stool samples assessed in 2023, 53% were delivered to the national polio laboratories within 72 hours compared to 52% of 8,666 AFP stool samples in 2022 (1% difference, p-value of 0.1838). There is an overall improvement in the Global Polio Surveillance Action Plan (GPSAP) indicators in the ESA subregion for the period of 1 January 2022 to 31 December 2023. We recommend utilizing innovative methods to improve case detections, providing tailored surveillance training to lower levels, and enhancing sample shipment and capacities to process samples timely.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.